NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Fri, 5 Jun · 09:58 IST

Intimation about Schedule of Analyst / Institutional Investor Meeting on June 11, 2026

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹16900.00
prior close
₹16945.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.0+0.4+0.3-0.1+1.8+0.0+0.1+1.8-1.1+7.2+12.1
Up moveDown movePending
AI summary

Neuland Laboratories Limited has informed the stock exchanges about an upcoming meeting with analysts and institutional investors scheduled for June 11, 2026. This is a routine disclosure required under SEBI regulations to ensure transparency regarding company interactions with market participants. The announcement does not contain any new financial results, business updates, or material information beyond confirming the date of the investor interaction. Investors often watch these meetings closely as companies sometimes share strategic updates or guidance during such interactions.

Likely market impact

This is a routine compliance disclosure with no direct impact on stock price. However, investors may anticipate potential updates or commentary from the company during the meeting that could influence sentiment in subsequent trading sessions.